Connection

David Priest to Neoplasms

Back to Details
This is a "connection" page, showing publications David Priest has written about Neoplasms.
David Priest
Connection Strength
0.020
Neoplasms
  1. Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res. 2000 Jul; 6(7):2677-84.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.